Transcription of vesicular stomatitis virus (VSV) in Vero cells was confined to the synthesis of parentally-derived mRNA (primary transcription) by the use of cycloheximide and/or a ts mutant, G4I(IV), at a non-permissive temperature (40 °C). More transcripts accumulated in the presence of cycloheximide than in its absence. This so-called 'cycloheximide effect' results from higher rates of virus transcription sustained for longer periods of time. The rate of VSV transcription initially increases linearly for I to 2 h after infection. Interferon reduces this rate (~_ fourfold with 50 units/ml interferon) irrespective of the presence or absence of cycloheximide. The VSV mRNA transcripts synthesized in mock-or interferontreated cells were equal in size and had an equivalent half-life of 17 h at 40 °C. It seems likely that once transcription is initiated in interferon-treated cells, it is completed successfully.
INTRODUCTION
Following the discovery of a virion-associated transcriptase in vesicular stomatitis virus (VSV) and its demonstration in vitro by Baltimore, Huang & Stampfer (I97O), we described an assay for the in vivo accumulation of transcription products in which inhibitors of protein synthesis, such as cycloheximide, were used to restrict transcripts to those originating from the parental genome, i.e. primary transcripts (Marcus et al. I970 . We demonstrated that chick embryo cells manifesting interferon-mediated interference accumulated, in a dose-dependent manner, fewer virus transcripts than mock-treated cells also infected in the presence of cycloheximide. These observations were confirmed and extended by Manders, Tilles & Huang (I972) using VSV in human muscle skin fibroblasts. Kiley & Payne, 1974; Woodson, I976) . Furthermore, cycloheximide and other inhibitors of protein synthesis enhance VSV transcription in vivo under certain conditions-the so-called ' cycloheximide effect' (Wong, Holloway & Cormack, 1972; Perlman & Huang, I973; Wertz & Levine, I973; Unger & Reichmann, 1973; Combard etal. ~974; Marcus & Sekellick, 1975) . In addition, cycloheximide might affect intracellular processes other than inhibition of protein synthesis (McMahon, 1975) .
In order to obviate aberrent effects attributable to the use of inhibitors of protein synthesis, we used a temperature-sensitive (ts) mutant which produces only parentally-derived transcripts at non-permissive temperatures. This communication describes the use of this mutant, tsG41(IV) (Pringle, 197o; Unger & Reichmann, I973) , to examine the effect of interferon action on primary transcription of VSV in green monkey kidney (Vero) cells. We compare the rates of virus transcription and transcript accumulation in the presence and absence of cycloheximide, and present evidence that (i) cycloheximide prolongs the initial increase in rate of primary transcription, creating the so-called 'cycloheximide effect', (ii) interferon acts to reduce the rate of primary transcription, and (iii) virus transcripts synthesized in both mock-and interferon-treated cells are equally long-lived.
METHODS
Cells. The Vero line, clone MS1, of green monkey kidney cells was used in all experiments reported here. The growth conditions and characteristics of these cells as maintained in our laboratory have been described (Marcus & Sekellick, 1974) .
Vesicular stomatitis virus (VSV).
The temperature-sensitive (ts) mutants GII4(I) and G41(IV) of Pringle, (197o) , and the Wlo(IV) mutant of Holloway, Wong & Cormack (197o) were used throughout this study. Our procedures for preparing stocks of ts mutants at 3o °C (permissive temperature) in monolayers of Vero cells have been described (Marcus & Sekellick, 1975) . Low multiplicity (m) infections with plaque forming particles (p.f.p.; rn~.f.p. = o-oooI to o.ooi) were used to obtain preparations free or low in defective interfering particles. At 30 °C the stocks usually assayed at 5 to 50 × ~o s p.f.p./mI. Revertant titres for ts mutants, G4I and WIo, measured at 40 °C (non-permissive temperature) were usually around lO 4 to io 5 p.f.p./ml. We have never detected revertants of G114 (Marcus & Sekellick, I975, footnote 2) .
Interferon and induction of virus interference. The human leucocyte interferon used throughout was supplied by T. C. Merigan. Its titre was 7"2 × IO 5 reference interferon units/ml and its specific activity 2.8 × Io ° reference interferon units/mg protein (based on the British human leucocyte standard 69/I9). In a plaque reduction assay with VSV in our Vero cells, this preparation led to a 5 o ~ reduction in plaque numbers at a concentration of I3"9 reference interferon units/ml. In some preliminary experiments, which are not reported, a much cruder preparation of interferon was used, produced by inoculating the M29L line of human fibroblasts (from D. H. Carver) with u.v.-irradiated Newcastle disease virus, and partial purification by perchloric acid treatment. This preparation gave results comparable to those described for the more purified material. Mock-interferon preparations were obtained by perchloric acid treatment of medium from mock-infected fibroblasts; these had no antiviral or anticellular activities, and had no adverse effect on cell-killing particle activity or on in vivo transcription (Marcus & Sekellick, I976 ) . Interferon-mediated interference was accomplished by exposing Vero cell monolayers to various concentrations of human interferon for 2o to z4 h at 37 °C. Mock-treated cells received mock interferon and were manipulated similarly.
Analyses of virus transcripts.
Cumulative synthesis. The in vivo assay for VSV-associated transcript accumulation in Vero cells was carried out basically as previously described (Marcus & Sekellick, I975, ~976) . Virus 0np~. -5oo) was adsorbed at 37"5 °C for 3 ° min, unadsorbed virus removed and r-o ml of pre-warmed standard reaction mixture (Marcus & Sekellick, I975: actinomycin D, Io/zg/ml; cycloheximide, 5o/zg/ml and 5-ZH-uridine, 5 to ~o #Ci/ml, sp. act. about z9 Ci/moI) in NCI medium (Marcus & Carver, I965) was added to each 35 mm dish. In some experiments, cycloheximide was omitted from the reaction mixture. Plates were incubated at 4o °C for appropriate periods before determining the amount of 3H-uridine incorporated into acid-insoluble material as previously described (Marcus et al. I97~) . Annealing of VSV virion RNA with the ZH-labelled product has established the radioactive material as virion-derived [+] strand mRNA-the product of primary transcription (Marcus et al. ~97I; Huang & Manders, I97z) .
Rate determination (pulse-label) . The rate of tsG4I(IV) RNA transcription at nonpermissive temperature (40 °C) -conditions which allow only the synthesis of primary virus transcripts (Unger & Reichmann, ~973) -was examined in mock-and interferon-treated Vero cells. Confluent monolayers of cells in 35 mm dishes were treated with I.o ml (5o units/ml) of interferon (mock interferon was diluted similarly) at 37"5 °C for zo h. Cell monolayers were pre-treated for 6o min with actinomycin D (~o #g/ml) at 37"5 °C and then infected with the ts mutant (mr.f. o. ~ IOOO), always in the presence of DEAE-dextran (~o #g/ml), at 37"5 °C for 3o min. Unadsorbed virus was removed by aspiration and o'5 ml of pre-warmed 4o °C nutrient medium (NCI) with actinomycin D (Io/zg/ml) and, when appropriate, cycloheximide (50 #g/ml), was added to each dish. Infected cell monolayers were incubated at 4o °C in a water-jacketed COs incubator. At appropriate intervals, o'5 ml of radioactive medium was added to each plate giving a final concentration of 3o/zCi of 5-aH-uridine (sp. act. 29 Ci/mmol) per plate, and incubation was continued at 4o °C for either 5 or 2o rain. At the end of the pulse labelling period, the radioactive medium was removed by aspiration and monolayers were solubilized and assayed for TCA-precipitable radioactivity as previously described (Marcus et al. ~97~) .
Sucrose gradient analysis. Confluent monolayers of Vero cells in ioo mm dishes were treated with 4"o ml of appropriately diluted human interferon (o, ~2"5, 25 or 5o units/ml in NCI medium with 6 ~ calf serum). Following incubation at 37"5 °C for 2o h, medium was removed, monolayers were washed twice with cold medium and ~-o ml of stock tsG4I t,. I. MARCUS AND M. J. SEKELLICK (mp.~p. --4OO) in DEAE-dextran 0o #g/ml) was adsorbed to each plate for 3o min at 4 °C-Unattached virus was removed by aspiration and 3"o ml of pre-warmed reaction mix containing Io/zg/ml actinomycin D and 4o#Ci 5-ZH-uridine (sp. act. 29 Ci/mmol) was added. In some experiments, the reaction mixture also included 5o #g/ml cycloheximide. Ceil monolayers were incubated at 37"5 °C for 2o rain and then shifted to 4 ° °C for 3 h.
At the end of the labelling period, radioactive medium was removed by aspiration and the cell monolayers were washed once with warm NT-5 × E (o.I M-NaC1, o.oi M-tris, pH 7"4, o'o05 M-EDTA). Cells were readily removed from each plate into 3"o ml of NT-5 × E by gentle pipetting with a Pasteur pipette. The high concentration of EDTA in this buffer facilitated the rapid removal from the plate of totally intact cells and obviated the need for scraping or trypsin treatment.
Cells were pelleted by centrifugation at Iooo rev/min for 5 min in an International Centrifuge (Model PR6). The supernatant fluid was decanted and the pelleted cells were washed once with ice-cold NT-5 x E. Each pellet was then resuspended in o'5 ml of I/Io NT-5 × E and the cells were allowed to swell for 20 min at 4 °C. Each cell suspension was taken up and expressed I2 times through a 25 gauge needle attached to a I ml syringe. Microscopic examination showed that virtually all the cells had been disrupted leaving the nuclei intact. This preparation was centrifuged at 2ooo rev/min for 5 min, and the pellets were discarded. SDS was added to each sample to a final concentration of 0"5 % prior to rapid freezing and storage at -7o °C.
Samples were layered on to I5 to 30 % sucrose-SDS-NTE gradients (o.I M-NaC1, o.oI M-tris, pH 7"4, o.oor M-EDTA, o'5 % SDS) and centrifuged in a Beckman SW4o rotor for ~7 h at 78 ooo g and 2o °C. Gradients were fractionated from the top, collected dropwise (2o drops per tube) and frozen at -2o °C.
For assay of radioactivity, 2oo/zg of yeast RNA was added to each tube, and then precipitated with an equal volume of IO % TCA. The mixture was held on ice for Io rain. Radioactive precipitates were collected by filtration on to Whatman GF/A filters and counted in a Packard Scintillation Spectrometer.
Use of a temperature-labile mutant, tsGH4(I) to achieve 'pulse-chase' conditions. VSV tsGI t4(1) with its thermolabile transcriptase (Pringle, I97o; Hunt & Wagner, ~974) was used to achieve a pulse-chase of virus mRNA synthesized in mock-and interferon-treated Vero cells. Following pre-treatment of confluent monolayers of cells in 35 mm dishes with 50 units of interferon or appropriately diluted mock-interferon (in NCI medium with 6 ~o calf serum) at 37"5 °C for 20 h, cells were treated with Io #g/ml of actinomycin D for 6o min at 37"5 °C, and then infected with tsGt I4(I) at mp.~. _ 5oo (in the presence of DEAEdextran, to/zg/ml) for 30 min at 37"5 °C. Unadsorbed virus was removed by aspiration, and o'5 ml of a reaction mixture of NCI containing to #g/ml actinomycin D and 5o/zg/ml cycloheximide was added to each plate. Primary transcription was allowed to proceed for 2 h at a permissive temperature (30 °C). A 5 min pulse of ongoing RNA synthesis (primary transcription) was accomplished by adding o'5 ml of this reaction mixture (at 3o °C) to each plate such that the final radioisotope concentration was 3o #Ci of 5,6-3H-uridine (sp. act. 37"6 Ci/mol) per ml per plate. After incubation at 30 °C for 5 min, medium was removed and the plates were set on to a large aluminium block in a 45 °C water bath while r-o mt of chase medium at 45 °C (NCI with IO #g/ml actinomycin D and t x to -4 M-uridine) was added to each dish. The plates were then immediately placed in a 4o °C water-jacketed, CO2 incubator for the chase period. Plates were removed at appropriate intervals and the cells solubilized and processed for TCA-precipitable radioactivity as previously described (Marcus et al. I970 . 
RESULTS
Both of the human interferon preparations used in our experiments were relatively crude, and consequently, we cannot ignore the possibility that they contain an activity, other than interferon, responsible for the effects described herein. However, the crude fibroblast interferon used in the preliminary experiments and the 'purified' leucocyte interferon used in the reported experiments produced comparable results when made equivalent on the basis of antiviral units or in terms of the inhibition of cell-killing particle activity (Marcus & Sekellick, ~976) .
Virus transcript accumulation by tsG41(IV) Transcript accumulation in the presence of cycloheximide
The time-course of transcript accumulation by VSV tsG41(IV) at 40 °C in mock-and interferon-treated Veto cells in the presence of cycloheximide is illustrated in Fig. I . In mock-treated cells, virus transcripts accumulated at a nearly constant rate for 6 h ( (IV) at 4o °C in the presence of cycloheximide (5o #g/ml). The RNA represents primary transcripts of VSV, and was extracted from the cells 3 h after infection and continuous labelling with 3H-uridine, as described in Methods. Cells treated for 24 h prior to infection with mock interferon ((3 O), or with interferon at I2.
demonstrating the stability and function of the virion-transcriptase complex of this ts mutant under our experimental conditions. In three separate experiments where cycloheximide was included in the reaction mixture, the amount of 3H-uridine incorporated from UTP into acid-precipitable virus transcripts, over a 6-h period of labelling in mock-treated cells, averaged I-4-fold (mean + standard deviation = I'4 + o'4) greater than the amount incorporated in the absence of the drug. These data are in good agreement with those of Unger & Reichmann (I973, their Fig. 4) , who studied this same ts mutant in BHK-2I cells.
When cycloheximide was present, 3H-virus RNA accumulation at 4o °C always exceeded that which accumulated at 3o °C. In its absence, virus RNA accumulation at 4 ° °C was about 9o % of that observed at 3o °C, but consisted solely of primary transcripts. When GMK Vero cells were treated with interferon and infected with tsG4I(IV) in the presence of cycloheximide, virus transcripts accumulated for a much shorter period of time than in mock-treated cells (Fig. I) . About 2 to 3 h after infection, the amount of virus Similar cultures of Vero cells treated with the same amount of interferon (5o units/ml) and challenged at 40 °C with wild type VSV (mpxp. = lO or IOO), produced IO-to 15-fold less virus than mock-treated cells, whether actinomycin D (Io/zg/ml) was present or not. Virtually all ceils can be protected from the lethal action of wild type virus at this dose of interferon (Marcus & Sekellick, 1976 ) . Fig. 2 . illustrates the effect of the interferon dose on the quantity and size distribution of the virus transcripts which accumulated during 3 h of continuous labelling with ZH-uridine. The RNA profile from mock-treated cells shows that large amounts of 12 to i8S mRNA accumulated, but very little of the 28S species (cf. Unger & Reichmann, I973) . This RNA profile resembles that produced by two other mutants of complementation group IV, as reported by Combard et aL 0974) in HeLa cells. In Fig. 2 , the curves formed by dashed lines represent, reading from the top down, RNA from cells treated with r2"5, 25, and 50 PRso units of interferon, respectively. These data demonstrate that the amount of virus transcripts which accumulate in cells over a 3-h period in the presence of cycloheximide decreases with increasing doses of interferon, P. I. MARCUS AND M. J. SEKELLICK * Virion-associated transcriptase activity was measured in vivo in mock-and interferon-treated (50 units/ ml) Vero cells as described in Methods. In this experiment, ct/min represent cumulative incorporation of 3H-uridine over a 6-h period at the permissive (30 °C) or non-permissive (4o °C) temperature and in the presence or absence of cycloheximide (50 #g/ml). All values have been corrected by subtracting the background radioactivity, i.e. between 5o0 and 1ooo ct/min, from appropriate uninfected cell cultures. The actual background levels may have been less because of virus-induced inhibition of cellular RNA synthesis (Marcus et al. I97I, Note no. 8) .
confirming an earlier observation in the VSV-chick embryo cell system (Marcus et al. I971) and a similar study on VSV transcript accumulation in human muscle skin fibroblasts (Manders et al. I972) . Although not illustrated, doses of interferon in excess of those used here were disproportionately less effective in reducing the accumulation of virus transcripts, and hence appeared to reveal a fraction of virus transcripts refractory to the action of interferon (cf. Fig. 3 and 4 in Marcus et al. I97I, and Table I in Manders et al. 1972) . The smallest species of RNA shown in Fig. 2 (and in Fig. 4) were not observed consistently.
Transcript accumulation in the absence of inhibitors of protein synthesis
The experiments described above also were carried out in replicate monolayer cultures, but with cycloheximide omitted from the reaction mixture during virus transcription. Fig. 3 shows that when virus transcription by tsG41(IV) took place at 4o °C under conditions which permit protein synthesis, the rates at which virus transcripts accumulated in mockand interferon-treated cells were similar for up to about 4 h after infection. These results are in contrast with those observed when cycloheximide is present (Fig. I) . We note that under these conditions, where protein synthesis was allowed, the high multiplicity of infection (m~.~p. ~-5oo) brought about a significant cytopathic effect by 5 to 6 h in both mock-and interferon-treated cells (cf. Yamazaki & Wagner, I97o) . Fig. 4 illustrates the profiles of RNA species that were isolated from Vero cells exposed to different doses of interferon, and infected with tsG4I(1V) for 3 h at 4o °C in the absence of cycloheximide. Under these conditions interferon treatment had little or no effect on the size distribution or quantity of virus transcripts which accumulated (contrast the interferon dose dependent reduction observed when cycloheximide was present - Fig. 2 ). As noted above, the smaller RNA species seen in the gradients representing two of the doses of interferon in Fig. 4 (and the mock sample in Fig. 2) were not always observed, and hence could not be considered significant.
Virus transcript accumulation by tsWio(IV) in the presence and absence of cycloheximide : the ' cycloheximide effect'
The results obtained with ts mutant G4r(IV) were not unique. The data in Table I show that tsWIo, another mutant from complementation group IV, behaved similarly. Thus, in the presence of cycloheximide, Vero cells treated with 5o PRs0 units of interferon and infected with tsWIo(IV) accumulated about threefold fewer virus transcripts than mocktreated cells, whether at a non-permissive (4o °C) or permissive (3o °C) temperature. More transcripts accumulated at the lower temperature, presumably because of increased stability of the virion-associated transcriptase complex. However, in the absence of cycloheximide, interferon action did not appear to affect the already low level at which virus transcripts accumulated at 4o °C. At a permissive temperature and in the absence of cycloheximide, i.e. when transcription and replication proceeded normally, virus RNA accumulated to high levels. Not surprisingly, under these conditions interferon action produced a significant inhibitory effect.
The data in Table I also demonstrate that tsWio(IV) manifests a significant so-called 'cycloheximide effect'. Other inhibitors of protein synthesis, e.g., purornycin, pactamycin, and fluorophenylalanine produce a similar effect. In the experiment illustrated here, the addition of cycloheximide (5o/zg/ml) to mock-treated Vero cells infected at 4o °C resulted in a 6.5-fold increase in tsWIo transcript accumulation over the 6-h incubation period. In an experiment reported previously, the cycloheximide present:absent ratio in tsWlo(IV) infected Vero cells was 7"4 (Table 2, in Marcus & Seketlick, I975). Accumulation of virus transcripts via the 'cycloheximide effect' does not lead to a more rapid rate of virus production upon removal of the drug and incubation of the virus-cell complexes at 3o °C (P. I. Marcus & M. J. Sekellick, unpublished observations).
In contrast to tsWIo(IV), tsG42(IV) produces only a minimal 'cycloheximide effect'. For example, after 6 h of transcription in mock-treated cells the amount of 3H-labelled VSV transcripts which accumulated with cyeloheximide present (Fig. I ), or absent (Fig. 3) , differed by only 15 ~ from the mean value of I9o5 o ct/min. At 4 h, this difference was 4I ~ from the mean value of 226oo ct/min. Differences in transcript accumulation in mocktreated cells in the presence and absence of cycloheximide as calculated from the gradients of Fig. 2 and 4 (for 3 h) and similar data (not shown) for 6 h, were, respectively, 54 ~ and 37 ~ of the mean value of total acid-precipitable nH-ct/min. These results agree well with a similar calculation we have made, based on data of Unger & Reichmann (~973, their 
Uridine uptake
The reduction in virus transcript accumulation observed in Vero cells treated with interferon and challenged with VSV in the presence of cycloheximide ( Fig. I and 2 , Table I ) might simply reflect a reduction in cell membrane permeability to ribonucleosides. Consequently, we determined the uptake of 3H-uridine into acid-soluble material in both mockand interferon-treated cells with conditions identical to those under which we measured virus transcript accumulation. Cells were infected at high multiplicity with tsG4I(IV), incubated at 4o °C in the presence or absence of cycloheximide and pulse-labelled with 3H-uridine for 5 min at hourly intervals for 5 h. The results of a typical experiment are displayed in Table 2 , and represent the mean value and standard deviation of the 5 individual hourly determinations for each of the experimental conditions tested. The narrow range of P. L MARCUS AND M. J. SEKELLICK 5o units/ml. § 5o #g/ml. the standard deviations (+ 7 to I5 ~) indicates that there was little variation in the uptake of ~H-uridine for any single experimental condition during the o to 5 h test period. The differences between the mean values of appropriately paired samples are considered within the range for sampling error except that in the last set of treatments, the 2o ~ difference borders on being significant. This, however, represents a change that would tend to minimize rather than maximize any inhibitor effect of interferon action on virus transcript accumulation due to a decrease in membrane permeability to the ribonucleoside. Our results agree with those of Genty (~975), who observed that uridine entry into HeLa or L-cells was little affected by infection with VSV.
The rate of virus transcription in the presence of cycloheximide
Using the pulse-labelling procedures described in Methods, we determined first the amount of virus transcripts which accumulated at 4o °C during a 5 rain pulse of 3H-uridine at various times after infection with tsG4I (IV) in the presence of cycloheximide. The amount of acid-precipitable 3H-ct/min was taken to represent the apparent rate of transcriptiona term which takes into consideration the sum of synthetic and degradative reactions extant during the time of labelling. Since it requires about 4 min or less to transcribe the entire genome of VSV in vivo (Flamand & Bishop, I974) , a 5 min pulse-interval should provide a close approximation to the absolute rate of transcription by minimizing the time available for degradation. Fig. 5 demonstrates that when cycloheximide was present during virus infection of mock-treated cells, the rate of transcription increased linearly for almost I h, reached a plateau, and then remained relatively constant and maximal over the next 4 h (I to 5 h post-infection). In the interferon-treated cells the rate of virus transcription initially also increased linearly, but at a significantly reduced rate. (In two 5-rain and 2o-min pulse experiments, there was an average fourfold reduction.) The maximal rate of transcription in interferon-treated cells was observed at about 2 h post-infection, and declined steadily over the next 3 h (2 to 5 h post-infection). In effect, with cycloheximide present, and corn- 
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The rate of virus transcription in the absence of added inhibitors of protein synthesis
Experiments identical to those described above were performed in parallel, but without cycloheximide in the reaction mixture. Fig. 6 (which may be compared directly with Fig. 5) shows that in mock-treated cells the rate of virus transcription initially increased rapidly for about I h, then decreased slowly over the next 4 h. In interferon-treated cells, and in the absence of cycloheximide, the initial rate of increase of virus transcription was slower than in mock-treated cells, reached its peak rate at about z h, and declined only slightly over the last 3 h of the experiment, i.e. 2 to 5 h post-infection. In three different experiments we observed that 50 units/ml of interferon produced an average threefold (extremes of twoto sixfold) reduction in the initial slope (rate-change) of the transcription rate-time curves. A 2o min pulse experiment produced similar results.
VSV transcription rate curves generated in mock-and interferon-treated cells in the absence of inhibitors of protein synthesis differed from each other much less than those generated with cycloheximide present (cf. Fig. 5 and 6 ). Thus, cumulative yield curves based on these data might as a first approximation, account for the results recorded in Fig. 3 
The half-life of virus transcripts: 'pulse-chase' experiments with tsGzz4(I )
We have taken advantage of the heat lability of the virion-associated L-protein (transcriptase) of VSV mutant tsGII4(I) (Szilfigyi & Pringle, I972; Perlman & Huang, 1973; Hunt & Wagner, I974; Marcus & Sekellick, I975) to develop a 'pulse-chase' procedure to determine the half-life of virus transcripts synthesized in mock-and interferon-treated cells. Monolayers were infected with tsGII4 at a permissive temperature (3o °C) in the presence of cycloheximide, and primary transcription (Marcus et aI. i971 ; Manders et aL x97z; Flamand & Bishop, I973) was allowed to proceed for z h in order to reach a high rate of synthesis (cf. Fig. 5 )-The infected cell monolayers were then labelled with ZH-uridine for 5 min (the pulse) while still at 3o °C. Upon completion of the pulse, medium containing radioisotope and cycloheximide was removed, and a new reaction mixture (containing Io -4 M-uridine, but without cycloheximide) at 45 °C was added and incubation immediately carried out at a non-permissive temperature, 4 ° °C (the chase). The virion-associated transcriptase quickly ceases to function at 4o °C and incorporation of radioisotope from the precursor pool is concomitantly arrested, creating conditions for an effective chase. The half-life of the virus transcripts synthesized under these conditions was measured by determining the amount of acid-precipitable 3H-ct/min extractable from the cells as a function of time after the pulse. Fig. 7 shows that in both mock-and interferon-treated cells, an increase in incorporation of labelled precursor continued for 3o rain after termination of the 5 min pulse with ~H-uridine -presumably reflecting the time required to inactivate the transcriptase in all transcribing complexes. After the first 30 rain, no further increase in acid-precipitable material was observed. Assuming little change in the specific activity of the UTP pool (Metz &~k Esteban, i972) , almost half of the virus transcripts were labelled during the 5 min pulse, and the other half during the first 3o min of the 'chase' period. Continued incubation of the infected cells for 3 h at 4o °C revealed a slight decrease in 
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DISCUSSION
Our data show that in mock-treated cells, larger amounts of primary transcripts accumulated in the presence of cycloheximide than in its absence. We have shown that this is due to higher rates of virus transcription sustained for longer periods of time. These results provide an explanation for the so-called 'cycloheximide effect', i.e. the enhanced accumulation of virus transcripts in the presence of inhibitors of protein synthesis. This effect may be large, as in cells infected with tsWIo(IV) (Table 0, smaller as with tsG4I(IV) (compare the mock-treated cells in the presence of cycloheximide in Fig. 2, 2 and 5 with those in the absence of cycloheximide in Fig. 3, 4 and 6) , or nonexistent when the mutant defect is a heat-labile virion-transcriptase as with tsGII4(I) ( Table I in Marcus & Sekellick,   I975) .
Basically, our data demonstrate that the rate of primary transcription of VSV initially increases linearly for about I to 2 h after infection, and that interferon acts to reduce this rate significantly (about fourfold for 50 units/ml interferon), irrespective of the presence or absence of cycloheximide (cf. Fig. 5 and 6 ). While the initial linear increase in the rate of primary transcription in mock-treated cells is essentially the same whether cycloheximide is present or absent, the action of the drug results in a higher and sustained rate of mRNA synthesis (cf. Fig. 5 and 6 ). The end result is to exaggerate the inhibition of virus transcription by interferon action when the drug is present (cf. Fig. I , 2 and 5 with 2, 3 and 6, respectively).
These results account for, and extend, earlier observations that fewer primary transcripts of VSV accumulate in interferon-treated than in mock-treated cells (Marcus et al. 197I; Manders et al. i972; Repik et al. I974, Fig. ID; Baxt et al. I977) , and that the sizedistribution of the transcripts is unchanged by interferon action (Manders et al. I972; Baxtet al. 1977) .
Use of data from Repik et al. (I974, Fig. I D) in support of our thesis that interferon action has an adverse effect on primary transcription of VSV may appear contradictory to their own interpretation, namely that '...interferon does not act at the level of primary transcription but rather at an intermediate step between primary and secondary transcription, such as viral protein synthesis.' However, it appears that during the determination of transcription (primary?) by VSV, cycloheximide was present in 'mock' control cells, but omitted from interferon-treated cells in several experiments (cf. their Fig. I A, B, C) . In the light of this and our present results, it would seem appropriate to view their interpretation of interferon action with reservation. As noted above, in the one experiment where cycloheximide was present in both' mock' and interferon-treated cells (their Fig. I D) , their data are totally supportive of our own (cf. Fig. 9 ) in VSV-infected monkey LLC-MK2 and human amnion U cells, with cycloheximide present. Thus, from four separate studies with VSVinfected cells, in addition to the present work, it is now abundantly clear that interferon action on cells reduced primary transcription to levels lower than those observed with cycloheximide alone (Marcus et al. I97t ; Manders et al. I972; Repik et al. I974; Baxtet al. I977) . Interferon action appears to have a greater effect than cycloheximide on the synthesis and accumulation of virus transcripts -even though the latter acts as an extremely efficient inhibitor of protein synthesis. Clearly then, interferon must have an effect on primary transcription beyond that attributable solely to protein synthesis inhibition. From the results presented here we propose that this additional effect is on the rate of primary transcription. As elaborated below, it is most likely that the effect is to block the initiation of transcription. We emphasize that these results do not preclude an additional and post-transcriptional mode of interferon action operative, for example, at the level of translation; and indeed, the data of Baxt et al. (I977) indicate that this mode of inhibition may be operative.
Since the VSV transcripts which do accumulate in interferon-treated cells appear to be normal in size and shape, as deduced from their behaviour during velocity sedimentation, it seems likely that once transcription has been initiated it is completed successfully, and that transcripts are not degraded significantly. From this inference we propose, as a working hypothesis, that interferon acts to decrease the probability, P, of initiation of VSV transcription for each transcribing nucleoprotein complex entering the cell (possibly for each round of transcription), with the value of P decreasing within limits with increasing doses of interferon. It is important to recognize that since transcription rate measurements are carried out at high multiplicities, they represent an average of the rates for all transcribing complexes in the population of infected cells. Conceivably then, at the single cell level, where infection by one virion may represent a real situation, an average reduction of, for example, fourfold in the transcription rate measured in a population of cells may actually reflect no (P = o) transcription initiation in 75 ~ of the cells (leading to cell survival), and normal (P = I) transcription initiation in 25 ~ (leading to cell death). Thus, inhibition of transcription might assume a significant role in the outcome of a virus-cell encounter when interferontreated cells are challenged with one, or a few, virion(s), as, for example, in a plaquereduction or cell killing particle assay (Marcus & Sekellick, I976 ) , or during natural infection. Experiments to test this hypothesis are planned.
Additional support for this hypothesis comes from a related study in which we observed that the dose-response curves for the loss of (i) cell-killing particle activity and (ii) virus transcript accumulation by VSV were essentially equivalent in interferon-treated cells, even though the former test measures the activity of a single virion while the latter measures that of hundreds of virions per cell (Marcus & Sekellick, r976 ) . Furthermore, if we assume that for a given dose of interferon each virion-cell interaction has the same low probability of initiating transcription then, predictably, increasing the multiplicity of infection would lead to successful transcription by some virus-cell complexes; this in turn would result in the accumulation of virus transcripts and, upon their successful translation into threshold amounts of minimally functional proteins, cell-killing would ensue, as was clearly demonstrated by Yamazaki & Wagner 0970). Since we know that inhibition of VSV plaque formation in GMK-Vero cells is five times more sensitive to interferon action than cell-killing particle activity or transcript accumulation, and that virus proteins N and NS need to be minimally functional to express cell-killing (Marcus & Sekellick, 1975, I976; Marvaldi et aL I977; Marcus et al. I977) , it seems likely that even though full-size transcripts may be available in interferon-treated cells multiply-infected with VSV, some additional facet of interferon action must be operative to inhibit virus replication at a later step, most likely inhibition of translation (Baxt et al. I977) .
If we assume that the size of ribonucleotide pools in Vero cells remains essentially unchanged following treatment with interferon, as Metz & Esteban (I972) have shown in mouse cells, our data indicate that changes in cell membrane permeability to ribonucleosides (Table 2) would not readily account for the elevated levels of transcript accumulation that constitute the cycloheximide effect in mock-treated cells, or for the reduced levels observed in interferon-treated cells.
For a transcribing negative-strand virus like VSV (or reovirus; Wiebe & Joklik, i975), models of interferon action which postulate a 'primary' effect on translation appear to ignore the mandatory sequence of primary transcription-+primary translation which is required before there can be any amplification of virus RNA synthesis and production of new virus. Inhibition of primary transcription would reduce the number of virus messages available for subsequent translation. Thus, if interferon action inhibits translation of virus messages, the overall effect will be greatly exaggerated if there is, in addition, an effect of interferon on primary transcription: this will mean that fewer virus messages are available for translation. This important point (first expounded by J. Taylor-Papadimitriou at the 5th Katzir-Katchalsky Conference in Rehovot, Israel, on May 4, I977) suggests that it may be prudent not to use the term 'primary effect' when referring to interferon action until such time as the relative contributions of transcription and translation inhibition are defined in more rigorous terms.
These data do not represent isolated observations. Interferon action has been reported to reduce to varying degrees the accumulation of transcripts in cells infected with such transcriptase-containing viruses as (i) frog polyhedral cytoplasmic deoxyribovirus (Gravell & Cromeans, I972) , (ii) influenza virus (Bean & Simpson, I973) , (iii) reovirus (Gauntt, I972; Wiebe & Joklik, 1975) , and (iv) one virus which apparently uses cellular RNA polymerase H for transcription, i.e. SV40 (Oxman & Levin, I97I; Metz, Levin & Oxman, I976) . We cite the study of Wiebe & Joklik (I975) in this context even though the major effect they observed appears to support their contention that '...the principal mechanism by which interferon inhibits reovirus replication is by inhibiting the translation of early reovirus mRNA.' Nonetheless, data in their Fig. 6 and 7 demonstrate that interferon treatment also reduced transcription of early mRNA (primary transcription), but produced no change in the size distribution of the transcripts. (It is important to note that their studies were also carried out in the absence of inhibitors of protein synthesis: Wiebe & Joklik used a ts mutant of reovirus with a defect which restricted mRNA synthesis to virion-derived primary transcription). When, as discussed above, the consequences of virus transcription and translation as sequential events are considered, the degree of translation inhibition which they recorded may not actually represent the full significance they ascribed to it.
Though the ' pulse-chase' procedure developed here is restricted to the use of ts mutants with appropriate phenotypes and hence is more limited in its range of usefulness than procedures which employ biochemical means to deplete the ribonucleotide pools (Wertz, i975) , the method does provide a means to measure the stability of virus RNA in cells under conditions where the precursor-pool is not altered by biochemical manipulations.
We note that the half-life of about I7 h recorded for VSV mRNA over a 3-h period in both mock-and interferon-treated cells is consistent with the stability of VSV transcripts in chick embryo cells as measured by Wertz (I975) over a I-h period. Furthermore, this observation is in keeping with results from recent experiments in which we failed to detect enhanced levels of ribonuclease (RNase) activity in interferon-treated Vero cells and mouse primary cultures, or in L-cells treated with interferon or poly(rI), poly(rC) under conditions where chicken and other avian embryo cells revealed high levels of single-and doublestranded RNase activity (Marcus, Terry & Levine, I975; Meegan, Fuller & Marcus, I976) . The absence of significant mRNA degradation under these experimental conditions also indicates that the transcription rate-curves generated by our pulse experiments provide a reasonably accurate assessment of virus transcription rate.
The evidence for in vivo stability of VSV mRNA in interferon-treated cells as reported here and by Manders et al. (I972) contrasts with the recent observations of Brown et al. (I976) who noted that reovirus mRNA was degraded in vitro by extracts from mouse Ehrlich ascites cells treated with interferon or poly(rI)-poly(rC) when double-stranded (ds) RNA was present (cf. May, Nagler & Graziadei, I975) . Since our studies with VSV were carried out under conditions which might minimize or preclude virus dsRNA formation, it is possible that insufficient dsRNA was synthesized in vivo to activate an endonucleolytic activity of this type. Further experiments should resolve this question.
Seemingly, viruses present a range of responses to the effects of the interferon system: for example, we note that in reovirus-(Wiebe & Joklik, I975) and VSV-(Baxtet al. I977) infected cells, a measurable reduction in transcript accumulation can be demonstrated under conditions where inhibition of translation also is manifested. In contrast, virion-associated early transcription by vaccinia virus is not sensitive to interferon action (Joklik & Merigan, i966; Jungwirth et aL I972; Metz & Esteban, I972; Esteban & Metz, I973) , whereas that of VSV is sensitive (Marcus et et al. (I976) . Thus, it seems prudent to recognize the possibility that the antiviral effects of interferon action, like those on the immune system, are multifaceted. This broader view may encourage a broader range of experimentation.
